While Multiple Myeloma can be deadly, research has helped prolong the lives of many people living with Multiple Myeloma.
More research is desperately needed to help give hope to people faced with a Multiple Myeloma diagnosis, particularly those at greater risk of succumbing to the disease.
Multiple Myeloma Support
Progressing research on the discovery of a unique protein that is overexpressed in 20-30% of Multiple Myeloma patients, with this group three-times more likely to die within six years of diagnosis.
Helping to control and improve the pain of myeloma patients who are treated with bortezomib, by understanding how changes in gut bacteria caused by bortezomib contribute to pain.